Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06854978 · ClinicalTrials.gov registry record · NA

R3THA Rehabilitation Feasibility and Usability Study

A NA study of Stroke, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06854978 is a NA study of Stroke that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06854978, a NA study of Stroke, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess how the Rehabilitation Technologies for Hand and Arm (R3THA) device can be used for rehabilitation of people with stroke. the study will evaluate the feasibility of R3THA as outpatient telerehabilitation administered by trained clinicians to individuals with stroke.

Conditions Studied

Interventions

  • OTHER RETHA

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-03-27
Est. Completion 2026-03-25
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT06854978

The ClinicalTrials.gov registry entry for NCT06854978 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which RETHA is the first listed.

NCT06854978 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06854978 about?

NCT06854978 is a clinical study titled "R3THA Rehabilitation Feasibility and Usability Study". The purpose of this study is to assess how the Rehabilitation Technologies for Hand and Arm (R3THA) device can be used for rehabilitation of people with stroke. the study will evaluate the feasibility of R3THA as outpatient telerehabilitation administered by trained clinicians to individuals with st...

What is the current status of trial NCT06854978?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-03-27. Estimated completion is 2026-03-25.

What conditions does trial NCT06854978 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06854978?

The interventions under investigation include: RETHA (OTHER).

Who is sponsoring clinical trial NCT06854978?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06854978 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.